Objectives: To investigate the effects of endotheline-1 (ET-1) receptor antagonism and/or chronic blockade of nitric oxide (NO) production on pregnancy outcome in the rat.
Methods: Pregnant or nonpregnant Wistar rats were either treated orally for up to 18 days with the NO-synthase inhibitor Nω-nitro-L-arginine methyl estr (L-NAME), the ETA-/ETB-receptor antagonist bosentan (Roche Basel, Switzerland) or both, or received no treatment (controls). Blood pressure, body weight, and drug intake were measured intervals. Pregnancy outcome and proteinurea were also determined. Analysis of variance and paired Student t test were used for statistical analysis.
Results: Chronic L-NAME treatment increased systolic blood pressure by 69 and 64 mmHg in pregnant and virgin rats respectively (P < .05). Bosentan-blunted, L-NAME-induced hypertension at the beginning (P < .05), but not at the end of the treatment period in all rats examined. Nω-nitro-L-arginine methyl ester-treatment in pregnancy reduced the number of living fetuses at term (P < .05) and caused proteinurea (P < .05). Bosentan tended to reverse the effects of L-NAME on fetus number and proteinurea, but both effects failed to reach statistical significance.
Conclusions: The effects of chronic NO-synthase-blockade on blood pressure in gravid rats can be reversed only temporarily by ETA-/ETB-antagonism, suggesting an involvement of endothelin-1 in the early phase of the L-NAME-induced, preeclampsia-like syndrome during pregnancy, although at later stages other mechanisms may come into play.
1. Lüscher TF, Vanhoutte PM. The endothelium: Modulator of cardiovascular function. Boca Raton: CR C Press, 1990.
2.
2. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol1994;24(Suppl 3):S16-S26.
3.
3. Rapoport RM, Murad F. Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res1983;52:352-357.
4.
4. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanoside monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest1989;83:1774-1777.
5.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988;332:411-415.
6.
6. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation1995;91:1314-1319.
7.
7. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
8.
8. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol1984;24:175-197.
9.
9. Rees DD, Palmer RMJ, Schulz R. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol1990;101:746-752.
10.
10. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest1990;85:587-590.
11.
11. Yokokawa K, Khono M, Yasunari K, Murakawa K, Horio T, Takeda T. Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension1991;18:304-315.
12.
12. Stewart DJ, Langleben D, Cernacek P, Cianflone K, Endothelin release is inhibited by coculture of endothelial cells with cells of vascular media. Am J Physiol1990;259:H1928-H1932.
13.
13. Yoshimoto S, Ishizaki Y, Sasaki T, Murota S. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke1991;22:378-383.
14.
14. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Ogihara T. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochemical Biophys Res Commun1989;159:1304-1308.
15.
15. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension1983;5:881-886.
16.
16. Lüscher TF, Vanhoutte PM. Endothelium-dependent responses to aggregating platelets and serotonin in spontaneously hypertensive rats. Hypertension1986;8 (Suppl 2):55-60.
17.
17. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension1993;21:929-933.
18.
18. Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation1995;91:2310-2313.
19.
19. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine cornary arteries: Role of scavenger receptor and endothelium-derived nitric oxide. Circulation1991;83:2012-2020.
20.
20. Grieff M, Lörtscher R, Shohaib SA, Stewart DJ. Cyclosporine induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation1993;56:880-884.
21.
21. Goerre S, Wenk M, Bartsch P, et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation1995;91:359-364.
22.
22. Boulanger C, Tanner FC, Hahn AWA, Werner A. Lüscher TF. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from the human and porcine endothelium. Circ Res1992;70:1191-1197.
23.
23. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N Engl J Med1990;323:1486-1487.
24.
24. Schiff E, Ben-Baruch G, Peleg E, et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol1992;166:624-628.
25.
25. MacGillivray I, Rose GA, Rowe B. Blood pressure survey in pregnancy. Clin Sci1969;37:395-407.
26.
26. Peeters LL, Grutters G, Martin CB. Distribution of cardiac output in the unstressed pregnant guinea pig. Am J Obstet Gynecol1980;138:1177-1184.
27.
27. Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol1992;80:1000-1006.
28.
28. Weiner CP, Thompson LP, Liu K, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol1992;166:1171-1181.
30. Bunag R, Butterfield J. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension1982;4:898-903.
31.
31. Takase H, Moreau P. Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dyfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension1996;27:25-31.
32.
32. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther1994;270:228-235.
33.
33. Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens Pregnancy1992;B11:117-129.
34.
34. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol1993;169:1316-1320.
35.
35. Molnár M, Süto T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinurea, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol1994;170:1458-1466.
36.
36. Helmbrecht GD, Farhat MY, Lochbaum L, et al. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol1996;175:800-805.
37.
37. Richard V, Hogie M, Clozel M, Löffler B, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation1995;91:771-775.
38.
38. Li JS, Larivière R, S chiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension1994;24:183-188.
39.
39. Masaki T, Usuki S, Yanagisawa M, Suzuki N. Endothelin in perinatal pharmacology. Semin Perinatol1991;15:27-29.
40.
40. Diket AL, Pierce MR, Munshi UK, et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol1994;171:1243-1250.
41.
41. Kurihara Y, Kurihara H, Suzuki H. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature1994;368:703-710.
42.
42. Jaffer FE, Knauss TC, Poptic E, Abbould HE. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int1990;38:1193-1198.
